Navigation Links
Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12

Federal, State and Local Officials Scheduled to Attend Ceremony

CHESTER, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) announced that it will commemorate the 10th anniversary of its incorporation with a celebration for employees on Wednesday, Sept. 12, at Municipal Field (Gazebo Park) in Chester, New Jersey. Federal, state and local officials are scheduled to attend and participate in a ceremony recognizing Adams for its decade of success as a specialty pharmaceutical company focused on the treatment of respiratory disorders.

Adams, best known for its Mucinex(R) and Delsym(R) cough and cold products and the nationwide Mr. Mucus(TM) consumer advertising campaign, commenced operations in Fort Worth, Texas in September 1997. In April 2004, the Company relocated its corporate headquarters from Fort Worth to Chester, New Jersey. Adams currently employees nearly 500 people and its Chester facility houses more than 80 of its employees. The Company has expanded its headquarter operations twice since relocating to Chester in 2004 and doubled its portfolio of marketed respiratory products this year.

"On the occasion of this important milestone, I applaud our employees, whose talents and tireless efforts have fueled Adams' phenomenal growth in the past several years," said Michael J. Valentino, president & CEO. "I'm proud of our accomplishments and I look forward to a second decade of success with multiple new product introductions and our planned expansion into the prescription respiratory market."

"I congratulate Adams Respiratory Therapeutics on its 10-year anniversary, and the tremendous growth and success that this company has achieved in such a short period of time," said Stanley Kosierowski, COO and SVP business support, New Jersey Economic Development Authority, who is scheduled to attend the celebration on September 12. "It is New Jersey's good fortune to have companies like Adams come to our state, where they create jobs, become good neighbors and corporate citizens, and continue New Jersey's fine tradition of improving public health by providing important medicines for the entire nation."

In August 2007, Adams was named to Deloitte & Touche's prestigious Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area. Adams was ranked No. 7 overall, based on achieving a revenue growth rate of 1,638 percent from 2002 to 2006.

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.

For additional information about Adams, please visit the web site at

SOURCE Adams Respiratory Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Passive smoking affects respiratory system
2. Occupational exposurer aises respiratory symptoms
3. Severe Acute respiratory Syndrome (SARS)
4. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
5. Good News for New Borns With Hypoxic Respiratory Failure
6. Understanding The Link Between Hormone Replacement and Respiratory Disease
7. Hand sanitizers may reduce respiratory and gastrointestinal infections at home
8. Antibiotics for acute uncomplicated lower respiratory tract infection
9. Handwashing prevents diarrhea and acute lower respiratory infections
10. New Virus Held Responsible For Respiratory Infection In Children
11. Second Hand Exposure To Smoke In Childhood Can Cause Respiratory Problems Later
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... December 01, 2015 , ... TCS Healthcare Technologies (TCS), ... population health arenas, is pleased to announce that VIP Care Services, a Caprock ... implemented the ACUITY Complete Care™ Management to back their collaborative catastrophic case management ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , a leader ... leadership since 2008. Gary Bruce, President of PartnerTech North America, currently serves as ... significant amount of time in Sweden since joining PartnerTech based in Malmo, Sweden. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Arash ... Modern Man for 2015. , Angeleno Magazine is a division of Modern ... in 1994, Modern Luxury includes more than 50 magazine titles across 15 major ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 ... addition of the "Veterinary Equipment and Disposables ... to 2020" report to their offering. ... of the "Veterinary Equipment and Disposables Market ... 2020" report to their offering. --> ...
(Date:12/1/2015)... , Dec. 1, 2015   MabVax Therapeutics Holdings, ... company, announces it has filed an Investigational New Drug ... (FDA) for the Company,s lead fully human antibody product ... acceptance, MabVax plans to initiate the Phase I clinical ... --> The planned Phase I trial ...
Breaking Medicine Technology: